by Dr. William Makis, Global Research:

Turbo cancer literature (15 papers):

(2024 Apr, Zhang and El-Deiry) – SARS-CoV-2 spike S2 subunit inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells

(2024 Apr, Rubio-Casillas et al) – Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?
(2024 Apr, Gibo et al) – Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan
(2023 Dec, Angues et al) – SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis
(2023 Nov, Patrick Chambers) – The CD147 Epitope on SARS CoV2 and the Spike in Cancer, Autoimmunity and Organ Fibrosis
(2023 Oct, Speicher et al) – DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events.